VFA
WST icon

Virtus Fund Advisers’s West Pharmaceutical WST Stock Holding History

Virtus Fund Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-217
Closed -$13K – 768
2015
Q4 		$13K Sell
217
-59
-21% -$3.55K ﹤0.01% 596
2015
Q3 		$15K Buy
+276
New +$16.1K ﹤0.01% 553
2014
Q3 		– Sell
-6,030
Closed -$254K – 1954
2014
Q2 		$254K Buy
+6,030
New +$258K ﹤0.01% 896

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Virtus Fund Advisers's WST Position: Q1 2016 in Review

Virtus Fund Advisers sold out of West Pharmaceutical (WST) in Q1 2016, closing a stake of 217 shares — an estimated $13K sold.

Virtus Fund Advisers first reported a position in WST in Q2 2014 and held it in 3 quarters. The position peaked at $254K in Q2 2014. 251 funds tracked by Wall St. Rank hold WST as of Q1 2016.

  • Virtus Fund Advisers reported no remaining West Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Virtus Fund Advisers sold 217 West Pharmaceutical shares in Q1 2016, an estimated $13K.
  • Virtus Fund Advisers first reported a position in West Pharmaceutical in Q2 2014 and held it in 3 quarters.
  • Virtus Fund Advisers's West Pharmaceutical position peaked at $254K in Q2 2014.
  • 251 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2016.

Based on Virtus Fund Advisers's 13F filing for Q1 2016, filed 11 May 2016.